Skip to main content
. 2022 Jun 3;9(4):1119–1128. doi: 10.1007/s40744-022-00466-5

Table 2.

Summary of HU changes from baseline, using the mean index values for all countries

n HA–HL n Placebo p value
HU change—mean index, mean ± SD
 Δ T1–T0 347 0.10 ± 0.14 345 0.08 ± 0.14 0.072
 Δ T6–T0 342 0.12 ± 0.17 343 0.09 ± 0.17 0.048
 Δ T12–T0 341 0.14 ± 0.17 336 0.11 ± 0.17 0.058
 Δ T18–T0 339 0.15 ± 0.17 330 0.12 ± 0.17 0.055
 Δ T24–T0 336 0.14 ± 0.17 327 0.12 ± 0.17 0.365

p value comparing the HA–HL to the placebo group using the one-way ANOVA test